China Life Insurance (2628) reported a robust financial performance for the first half of 2025, with its net profit soaring by 6.9% to reach 40.931 billion yuan (HK$44.45 billion), according to the company’s semi-annual report released on August 27. Concurrently, the company proposed an interim dividend of 23.8 fen per share.
Several key business metrics also demonstrated remarkable growth. The new business value surged by more than 20% to 28.546 billion yuan.
Gross written premiums climbed 7.3% to a record 525.088 billion yuan. Revenue increased by 2.2% to 239.235 billion yuan.
By the end of June, total assets had reached nearly 7.3 trillion yuan, and the embedded value rose 5.5% to 1.48 trillion yuan.
In addition, China Life has been continuously expanding its medium- and long-term investments. Since the beginning of the year, open market equity has increased by over 150 billion yuan, and cumulative private securities investments have reached 35 billion yuan.
Related topics:
